The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of autonomic dysfunction on function, toxicity, and survival in patients with lymphoma treated with CART.
 
Kanithra Sekaran
No Relationships to Disclose
 
Ishan Roy
No Relationships to Disclose
 
Shuo Ma
No Relationships to Disclose
 
Jane Winter
Honoraria - Merck
Consulting or Advisory Role - Ariad (I); Biomea Fusion (I); Bristol Myers Squibb; CVS Caremark (I); Daiichi Sankyo (I); Epizyme (I); Genentech; Novartis (I); Novartis (I)
Research Funding - Astellas Pharma (I); Astellas Pharma (I); Biomea Fusion (I); Cellectis (I); Daiichi Sankyo (I); Merck; Novartis (I)
Patents, Royalties, Other Intellectual Property - Royalties from UptoDate for editoring; Royalties from UptoDate, Inc. (I)
 
Leo Gordon
Stock and Other Ownership Interests - Zylem
Consulting or Advisory Role - Bristol Meyers Squibb; Kite, a Gilead company; Ono Pharmaceutical
Patents, Royalties, Other Intellectual Property - Zylem
 
Kenneth Carson
Employment - Tempus
Leadership - Tempus
Stock and Other Ownership Interests - Tempus
Expert Testimony - Bayer
 
Adam Lin
Speakers' Bureau - Abbvie; Genmab
 
Jonathan Moreira
No Relationships to Disclose
 
Reem Karmali
Honoraria - Bio Ascend; Prime Oncology
Consulting or Advisory Role - AstraZeneca; AvenCell; Bristol-Myers Squibb/Celgene/Juno; Bristol-Myers Squibb/Celgene/Juno; Bristol-Myers Squibb/Celgene/Juno; Calithera Biosciences; EUSA Pharma; Genentech/Roche; Genmab; Gilead Sciences; Kite/Gilead; Lilly; Miltenyi Biotec
Speakers' Bureau - AstraZeneca; BeiGene; Bristol-Myers Squibb/Celgene/Juno
Research Funding - Abbvie/Genentech (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Gilead Sciences (Inst); Merck (Inst); Miltenyi Biotec (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Prime Oncology